ArticleTranslational cancer research2020

Antitumor activity and safety of sirolimus for solid tumors with PIK3CA mutations: A multicenter, open-label, prospective single-arm study (KM 02-01, KCSG UN17-16).

Seonggyu Byeon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.